Nadine Hillock

Dr Nadine Hillock

Research Associate

School of Public Health

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

Dr Nadine Hillock is a public health pharmacist with expertise in antimicrobial stewardship and resistance, health policy and economics and project management. She is the Manager of the National Antimicrobial Utilisation Surveillance Program in Australia.

She has a Bachelor of Pharmacy and Postgraduate Diploma in Clinical Pharmacy from the University of Otago (NZ), a Masters in Public Health from the University of Sydney and a PhD from the University of Adelaide. Her PhD thesis was titled Investigating an alternative regulatory and reimbursement framework for antimicrobials in Australia. Her current research interests include pharmacoepidemiology, antimicrobial surveillance methodology, antimicrobial stewardship and health economics.

Dr Hillock has over 25 years experience in healthcare across a variety of sectors including hospital, community, industry and government.

She is a member of a number of national and state committees, including:

- Australian Antimicrobial Stewardship Advisory Committee
- South Australian expert Advisory Group on Antimicrobial Resistance (SAAGAR)
- South Australian Antimicrobial Resistance Action Plan Steering Committee (SAAMRAP)
- Antimicrobial Stewardship Jurisdictional Network

Dr Hillock is a regular peer reviewer for the Australian Health Review, PharmacoEconomics and JAC-Antimicrobial Resistance journals, as well as a number of other peer-reviewed journals and conferences. As a consultant, she has provided expert advice to reviews commissioned by the Australian Government Department of Health and Aged Care.

Dr Hillock's current research interests include antimicrobial surveillance methodology, antimicrobial stewardship, pharmacoepidemiology and public health.  

 

  • Appointments
    Date Position Institution name
    2023 - 2025 Affiliate Senior Lecturer University of Adelaide
    2019 - ongoing Senior Pharmacist | Program Manager, National Antimicrobial Utilisation Surveillance Program (NAUSP) SA Health
    2016 - 2019 Public Health Pharmacist SA Health
    2016 - 2016 Clinical Pharmacist / Practice Support Drug & Therapeutics Information Service (DATIS), SA Health
    2015 - 2015 Tutor Public Health, University of Adelaide, Adelaide
    2010 - 2016 Senior Pharmacist South Australian Medicines Evaluation Panel, SA Health
    2009 - 2010 Project Pharmacist National Antimicrobial Utilisation Serveillance Programs (NAUSP)
    2007 - 2009 Production Pharmacist Flinders Medical Centre, SA Health
    2005 - 2016 Radiopharmacist Lantheus Medical Imaging (formally Bristol-Myers Squibb Medical Imaging)
    1998 - 2004 Community Pharmacist / Dispensary Manager Christchurch, NZ
    1997 - 1997 Aseptic services / Oncology pharmacist Hawkes Bay District Health Board, NZ
    1996 - 1997 Locum hospital pharmacist Australia & UK
    1994 - 1996 Clinical Pharmacist St George Hospital, Sydney
    1993 - 1994 Intern Pharmacist Tairawhiti District Health Board, NZ

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2019 Award Neville Derrington Hicks PhD Scholarship in Public Health Policy University of Adelaide Australia -
    2017 Scholarship Divisional Scholarship, Faculty of Health Sciences University of Adelaide - -
    2014 Award SA Health Award - Excellence in non-clinical services (SAMEP) SA Health - -

  • Education
    Date Institution name Country Title
    2017 - 2022 University of Adelaide, Adelaide Australia Doctor of Philosophy
    2010 - 2013 University of Sydney, Sydney Australia Master of Public Health
    1997 - 2000 University of Otago, Dunedin New Zealand Post-graduate diploma in Clinical Pharmacy
    1988 - 1992 University of Otago, Dunedin New Zealand Bachelor of Pharmacy

  • Postgraduate Training
    Date Title Institution Country
    2023 - 2023 Applied Learning Health Systems University of Melbourne Australia
    2021 - 2021 Leading Clinicians Program SA Health Australia
    Health Technology Assessment University of Adelaide Australia
    Financial Planning Massey University, Palmerston North New Zealand
    Radiation safety & radiopharmaceutical manufacturing BMS Medical Imaging Australia

  • Certifications
    Date Title Institution name Country
    — Registered Pharmacist Australian Health Practitioner Regulation Agency (AHPRA) -

  • Research Interests
    Antimicrobial Resistance Clinical Pharmacy and Pharmacy Practice Health Economics Health Policy Population Health Public Health

  • Journals
    Year Citation
    2023 Teoh, A. P. K., & Hillock, N. (2023). Antimicrobial-impregnated bone cement use in Australian hospitals: scoping pharmacist awareness and involvement in management. Journal of Pharmacy Practice and Research, 53(2), 73-78.
    DOI
    2023 Hillock, N. T., Campbell, D. G., Nelson, R., Teoh, A., Tan, J., & Smitham, P. (2023). Antimicrobial-loaded bone cement use is highly variable in joint replacement surgery: a survey of Australian arthroplasty surgeons. ANZ Journal of Surgery, 93(6), 1467-1470.
    DOI
    2023 Lai, T., Thiele, H., Rogers, B. A., Hillock, N., Adhikari, S., McNamara, A., & Rawlins, M. (2023). Exploring the advancements of Australian OPAT. Therapeutic Advances in Infectious Disease, 10, 12 pages.
    DOI
    2022 Connor, E., Rasiah, K., & Hillock, N. (2022). Utilisation of antimicrobials used to treat bacterial pneumonia in principal referral hospitals during the COVID-19 pandemic, Australia, 2020. Communicable diseases intelligence (2018), 46, 14 pages.
    DOI WoS1
    2022 Hillock, N. T., Merlin, T. L., Turnidge, J., & Karnon, J. (2022). Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy. Applied Health Economics and Health Policy, 20(4), 479-486.
    DOI Scopus9 WoS5 Europe PMC3
    2022 Macauley, G., Penny, M., McNeil, V., Gustafsson, T., & Hillock, N. (2022). Impact of expired stock on antimicrobial surveillance in rural hospitals: implications and challenges for stewardship. Journal of Pharmacy Practice and Research, 52(5), 370-376.
    DOI
    2021 Hillock, N. T., Merlin, T. L., Karnon, J., Turnidge, J., & Eliott, J. (2021). Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective.. International journal of technology assessment in health care, 37(1), 1-7.
    DOI Scopus1 WoS1 Europe PMC1
    2021 Hillock, N. T., Connor, E., Wilson, C., & Kennedy, B. (2021). Comparative analysis of Australian hospital antimicrobial utilization, using the WHO AWaRe classification system and the adapted Australian Priority Antimicrobial List (PAL). JAC-Antimicrobial Resistance, 3(1), 5 pages.
    DOI Scopus2 WoS4 Europe PMC2
    2021 Lambert, R., Burgess, N., Hillock, N., Gailer, J., Hissaria, P., Merlin, T., . . . Hill, C. (2021). South Australian Medicines Evaluation Panel in review: providing evidence-based guidance on the use of high-cost medicines in the South Australian public health system. Australian Health Review, 45(2), 207-213.
    DOI
    2020 Hillock, N. T., Karnon, J., Turnidge, J., & Merlin, T. L. (2020). Estimating the utilisation of unregistered antimicrobials in Australia. Infection, Disease and Health, 25(2), 82-91.
    DOI
    2020 Hillock, N. T., Merlin, T., Karnon, J., Turnidge, J., & Eliott, J. (2020). Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study. Journal of Antimicrobial Chemotherapy - Antimicrobial Resistance, 2(2), 1-7.
    DOI Scopus3 WoS2 Europe PMC1
    2019 Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Clinical indications treated with unregistered antimicrobials: The regulatory challenges of antimicrobial resistance and access to effective treatment for patients. Australian Health Review, 44(2), 263-269.
    DOI Scopus2 WoS1 Europe PMC1
    2019 Hillock, N., Hillock, R., & Warner, M. (2019). Antibacterial envelope to prevent cardiac implantable device infection. New England Journal of Medicine, 381(18), 1782.
    DOI Scopus1 WoS1 Europe PMC2
    2018 Hillock, N. (2018). Is obesity fake news?. Pharmacy Growth, Research, Innovation and Training, 2(4).
    DOI
    2017 Hillock, N. T., Heard, S., Kichenadasse, G., Hill, C. L., & Andrews, J. (2017). Infliximab for ipilimumab-induced colitis: A series of 13 patients. Asia-Pacific Journal of Clinical Oncology, 13(5), e284-e290.
    DOI Scopus30 WoS19 Europe PMC12
    2016 Hillock, N. (2016). The challenge of costly drugs. Australian Prescriber, 39(5), 149.
    DOI

  • Conference Papers
    Year Citation
    2022 Connor, E., & Hillock, N. (2022). 57: NAUSP METHODOLOGY UPDATES AND APPLICATION OF THE PRIORITY ANTIBACTERIAL LIST IN AUSTRALIAN ACUTE-CARE HOSPITALS, 2019–21. In Journal of Global Antimicrobial Resistance Vol. 31 (pp. S33-S34). Elsevier BV.
    DOI

  • Conference Items
    Year Citation
    2024 Hillock, N., Maher, D., Dalwai, A., & Connor, E. (2024). Trends in systemic antifungal usage rates in Australian hospitals: 2018-2022 (poster). Poster session presented at the meeting of Antimicrobials 2024: 23rd Annual Scientific Meeting. Sydney.
    2024 Maher, D., Sluggett, J., Soriano, J., Hull, D. -A., & Hillock, N. (2024). Surveillance of antimicrobial use in residential aged care: An Australian antimicrobial mapping survey. Poster session presented at the meeting of Antimicrobials 2024: 23rd Annual Scientific Meeting.
    2024 Hillock, N. (2024). NAUSP: Data update and future opportunities (oral). Poster session presented at the meeting of Antimicrobials 2024: 23rd Annual Scientific Meeting.
    2023 Hillock, N., Connor, E., & Dalwai, A. (2023). Antifungal usage rates in Australian hospitals. Poster session presented at the meeting of Antimicrobials 2023: 22nd Annual Scientific Meeting. Brisbane.
    2023 Hillock, N. (2023). Antimicrobial-loaded bone cement in prosthetic joint surgery: Current practice and opportunities for antimicrobial stewardship (oral presentation). Poster session presented at the meeting of Antimicrobials 2023: 22nd Annual Scientific Meeting. Brisbane.
    2021 Hillock, N., Connor, E., & McNeil, V. (2021). Hospital antibiotic use during the first COVID-19 wave in Australia (online oral presentation). Poster session presented at the meeting of ASA online.
    2020 Wilson, C., Connor, E., & Hillock, N. (2020). Increasing antifungal use in Australian hospitals (poster presentation). Poster session presented at the meeting of National Centre for Antimicrobial Stewardship Antimicrobial Awareness Week Online.
    2020 Wilson, C., Connor, E., & Hillock, N. (2020). Increasing antifungal use in Australian hospitals (poster presentation). Poster session presented at the meeting of National Centre for Antimicrobial Stewardship Antimicrobial Awareness Week Online.
    2019 McNeil, V., Hillock, N., & Warner, M. (2019). The South Australian Expert Advisory Group on Antimicrobial Resistance: 10 years progress and challenges. Poster session presented at the meeting of Australian Society for Antimicrobials 2019. Sydney.
    2019 Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2019). Policy incentives for a sustainable antibiotic market: the perspective of Australian stakeholders - a qualitative study (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019.
    2019 Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Special Access Scheme Category C and antimicrobial drugs - a policy solution or a temporary fix? (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019.
    2018 Hillock, N. T. (2018). Antimicrobial drugs and the Special Access Scheme: an anomaly or a marker of a system in crisis (Oral presentation). Poster session presented at the meeting of National Medicines Symposium. Canberra.
    2017 Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2017). Investigating the utilisation of unregistered antimicrobial drugs in Australia. Poster session presented at the meeting of Florey Postgraduate Research Conference. Adelaide.
    2016 Hillock, N. T. (2016). Nuclear medicine and the clinical pharmacist: a pathway to incorporating radiopharmaceuticals in the medication management process. Poster session presented at the meeting of National Medicines Symposium. Canberra.
    2016 Hillock, N. T. (2016). Starting from scratch: The South Australian Medicines Evaluation Panel (oral presentation). Poster session presented at the meeting of Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium. Ottawa.
    2015 Hillock, N. T., Selva-Nayagam, S., Hill, C., & Gailer, J. (2015). How systematic review methodology can mislead: Adalimumab versus infliximab for the treatment of Hidradenitis suppurativa (poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Melbourne.
    2014 Hillock, N. T., Gailer, J., Rolan, P., & Hill, C. (2014). South Australian Medicines Evaluation Panel: Evolution from inception to now (poster presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane.
    2014 Gailer, J., Hillock, N. T., Hill, C., & Louise, J. (2014). How to count the eggs? An ethical dilemma (poster presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane.
    2014 Louise, J., Della Flora, E., & Hillock, N. (2014). Patient self-funding of high cost medications - what are the ethical issues? (oral presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane.
    2013 Hillock, N. T., Ward, M., Rolan, P., & Hill, C. (2013). A statewide evaluation process for high cost medicines: The challenges of a poor evidence base (poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Cairns.
    2013 Hillock, N. T., Ward, M., Rolan, P., & Hill, C. (2013). Defibrotide for treatment or prophylaxis of veno-occlusive disease: What is the evidence? (Poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Cairns.

  • Internet Publications
    Year Citation
    2016 Hillock, N. T. (2016). Total knee arthroplasty: Continuous passive motion (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Post-stroke fatigue: Assessment (Scales) (Evidence Summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Autism Spectrum Disorders: Omega-3 Fatty Acids (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Autism Spectrum Disorders: Gluten-Free Casein-Free Diet (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Psoriasis: Topical treatments for Chronic Plaque Psoriasis (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Cerebral palsy: Speech and Language Therapy for Communication (Children) (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Post-stroke fatigue: Management (Evidence summary). Joanna Briggs Institute EBP Database.

  • Current Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2024 Co-Supervisor Development of antimicrobial stewardship programs to limit inappropriate antimicrobial prescriptions for presumed UTIs in residential aged care facilities. Master of Philosophy (Public Health) Master Full Time Miss Maria Lin

  • Committee Memberships
    Date Role Committee Institution Country
    2022 - ongoing Member SA Antimicrobial Resistance Action Plan Steering Committee SA Health Australia
    2019 - ongoing Member AMS Advisory Committee ACSQHC Australia
    2019 - ongoing Member Inter-jurisdictional Antimicrobial Stewardship committee National Centre for AMS Australia
    2019 - ongoing Member Australian Walking and Cycling Conference Organising Committee Australian Walking and Cycling Conference Australia
    2017 - ongoing Member South Australian expert Advisory Group on Antimicrobial Resistance (SAAGAR) SA Health Australia
    2015 - 2017 Member Australian Rheumatology Association - Therapeutics Subcommittee - Australia
    2010 - 2016 Co-Founder South Australian Medicines Evaluation Panel SA Health Australia

  • Memberships
    Date Role Membership Country
    2017 - ongoing - Australian Society for Infectious Diseases (ASID) -
    2017 - ongoing - Australian Society of Antimicrobials -
    2016 - 2016 Member Health Technology Assessment International (HTAi) -
    2014 - ongoing - Public Health Association of Australia -
    2013 - ongoing - International Society for Pharmacoeconomics and Outcomes Research (ISPOR) -
    2008 - ongoing - Society of Hospital Pharmacists of Australia -

  • Review, Assessment, Editorial and Advice
    Date Title Type Institution Country
    2019 - ongoing Peer reviewer, Am J Inf Cont Peer Review American Journal of infection Control -
    2019 - ongoing Peer reviewer, Aust Hlth Rev Peer Review Australian Health Review -
  • Position: Research Associate
  • Phone: 83136580
  • Email: nadine.hillock@adelaide.edu.au
  • Campus: North Terrace
  • Building: Rundle Mall Plaza, floor 4
  • Org Unit: Adelaide Health Technology Assessment
Connect With Me
External Profiles